INTERNATIONAL PATENT: EPICS THERAPEUTICS FILES APPLICATION FOR "PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS FOR THE TREATMENT OF CARCINOMAS"

GENEVA, Jan. 26 -- EPICS THERAPEUTICS (rue Adrienne Bolland 476041 Gosselies) filed a patent application (PCT/EP2025/070626) for "PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS FOR THE TREATMENT OF CARCINOMAS" on Jul 18, 2025. With publication no. WO/2026/017846, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SORLET, Catherine (c/o EPICS THERAPEUTICSrue Adrienne Bolland 476041 Gosselies), PARMENTIER, Nicolas (EPICS THERAPEUTICSrue Adrienne Bolland 476041 Gosselies), OUKOLOFF, Killian (c/o EPICS THERAPEUTICSrue Adrienne Boll...